What factors of GLP-1 coverage drive up premiums Using data from MarketScan and research by Blue Health Intelligence (BHI), the EBRI report models how GLP-1 coverage could affect employer-sponsored insurance premiums, exploring several scenarios based on: Drug pricing Net costs range from $617 to $766 per 30-day supply Patient adherence Perfect adherence leads to higher premiums due to sustained drug use Eligibility criteria Including overweight individuals with at least one weight-related condition significantly increases cost burden Cost-sharing Cost-sharing structures such as $90 copays help but dont eliminate increases Usage is growing More than 57 million privately insured adults qualify for GLP-1 drugs, like Ozempic and Wegovy
Arabidopsis thaliana -glutamylcysteine synthetase is structurally unrelated to mammalian, yeast, and Escherichia coli homologs
These agents, though not yet part of mainstream treatment guidelines, offer promising adjunctive strategies for individuals in early recovery and beyond
Interested in learning more about the new Medicare GLP-1 Bridge program
If you're still experiencing fatigue, brain fog, or lingering gastrointestinal symptoms from COVID (sometimes called 'long COVID'), inform your PlexusDx provider before restarting so they can help you determine whether a 1-week delay might be beneficial